Evidence map›Paper›PMID 41728447›Full record

ArticleCureus2026

Too Massive and Too Atypical to Be Benign: The Unexpected Face of a Giant Adrenal Myelolipoma.

Ijdda Sara, Boukhalfa Ahmed, Ghizlane Elmghari, Nawal El Ansari

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ijdda SaraDepartment of Endocrinology, Diabetology, Metabolic Diseases and Nutrition, Mohammed VI University Hospital, Marrakech, MAR.
Boukhalfa AhmedFaculty of Medicine and Pharmacy of Marrakech, Arrazi Hospital, Mohammed VI University Hospital Center, Marrakech, MAR.
Ghizlane ElmghariDepartment of Endocrinology and Metabolic Diseases, Arrazi Hospital, Mohammed VI University Hospital Center, Marrakech, MAR.
Nawal El AnsariDepartment of Endocrinology, CHU (Centre Hospitalo-Universitaire) Mohammed VI, Marrakech, MAR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adrenal myelolipomas (AMLs) are rare benign tumors composed of adipose and myeloid tissue. They are most often discovered incidentally and generally remain small in size. However, giant forms can radiologically mimic a malignant tumor, leading to aggressive investigations and treatment. We report the case of a patient who was hospitalized for investigation of a right adrenal mass, revealed by lumbar pain. An abdominal CT scan showed a large, heterodense interhepatorenal mass exerting a mass effect on the ipsilateral kidney with peripheral calcifications. The mass was excised and submitted for histological evaluation. The results of the histological study revealed an AML. Giant myelolipomas are rare and represent a real diagnostic challenge. Their large size, heterogeneous components, and necrotic or hemorrhagic changes can mimic a malignant tumor. Surgery remains indicated in cases of diagnostic uncertainty, compressive symptoms, or tumors larger than 6 cm. Histology remains the only way to establish a definitive diagnosis. This case highlights the difficulty of distinguishing a giant myelolipoma from a malignant adrenal tumor.

Indexed as

adrenal glandadrenal myelolipomacase reportgiant adrenal masstumor

Identifiers

PMID41728447
PMCPMC12921454

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.